RAF265 enafil dihydrochloride LCZ696 could inhibit the expression

LCZ696 could inhibit the expression of ANP

PF 4800567 is a novel and potent inhibitor of casein kinase 1 epsilon (IC50=32 nM) with greater than 20-fold selectivity over casein kinase 1 delta(IC50=711 nM)

Tegatrabetan (BC2059) is an antagonist of β-Catenin

Cancer Cell

Its main effects are dilation of the arteries supplying blood to the legs and decreasing platelet coagulation

RAF265 enafil dihydrochloride LCZ696 could inhibit the expressionCHIR 265 is an orally bioavailable small molecule with potential antineoplastic activity. CHIR 265 binds and inhibits Raf kinases, which may result in a reduction of tumor cell growth and proliferation, and tumor cell death. In addition, this agent inhibits vascular endothelial growth factor receptor type 2 (VEGFR 2), thereby disrupting tumor angiogenesis. Raf kinases are critical enzymes in the Ras Raf MEK ERK signaling pathway and are frequently